Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States. Bone Marrow Transplant 2023 Dec;58(12):1400-1402
Date
09/07/2023Pubmed ID
37673983DOI
10.1038/s41409-023-02102-4Scopus ID
2-s2.0-85170080925 (requires institutional sign-in at Scopus site)Author List
Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza AAuthors
Anita D'Souza MD Associate Professor in the Medicine department at Medical College of WisconsinWilliam R. Drobyski MD Professor in the Medicine department at Medical College of Wisconsin
Mary Eapen MBBS, DCh, MRCPI, MS Professor in the Medicine department at Medical College of Wisconsin
Liliana Pezzin PhD, JD Professor in the Institute for Health and Equity department at Medical College of Wisconsin
Anthony E. Zamora PhD Assistant Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
DemographyHumans
Immunotherapy, Adoptive
Multiple Myeloma
Receptors, Antigen, T-Cell
United States